NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 31 filers reported holding NRX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,981 | -58.6% | 19,158 | -22.9% | 0.00% | – |
| Q2 2023 | $12,019 | -14.5% | 24,858 | +16.6% | 0.00% | – |
| Q1 2023 | $14,056 | -72.8% | 21,326 | -54.1% | 0.00% | – |
| Q4 2022 | $51,619 | -38.5% | 46,504 | -59.1% | 0.00% | – |
| Q3 2022 | $84,000 | -19.2% | 113,584 | -34.3% | 0.00% | – |
| Q2 2022 | $104,000 | +25.3% | 172,923 | +410.3% | 0.00% | – |
| Q1 2022 | $83,000 | +176.7% | 33,888 | +441.4% | 0.00% | – |
| Q4 2021 | $30,000 | -57.1% | 6,259 | -17.4% | 0.00% | – |
| Q3 2021 | $70,000 | – | 7,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
| Virtu Financial LLC | 46,210 | $30 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
| UBS Group AG | 18,611 | $12,265 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
| OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |